Biocept (NASDAQ: BIOC)
|Date||Analyst Firm||Analyst Name||Action||Rating||Action Price||Prior Price||Target|
You can purchase shares of Biocept (NASDAQ: BIOC) through any online brokerage.
The latest price target for Biocept (NASDAQ: BIOC) was reported by Maxim Group on Tuesday, March 26, 2019. The analyst firm set a price target for 3.00 expecting BIOC to rise to within 12 months (a possible 154.24% upside). 0 analyst firms have reported ratings in the last year.
The stock price for Biocept (NASDAQ: BIOC) is $1.18 last updated August 11, 2022, 7:57 PM UTC.
There are no upcoming dividends for Biocept.
Biocept’s Q2 earnings are confirmed for Tuesday, August 23, 2022.
There is no upcoming split for Biocept.
Biocept is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.